Evidence shows that BCL-xL and MCL-1 are targets of miR-133a, and over-expression of miR-133a inhibits cell proliferation and promotes cell apoptosis of osteosarcoma cell lines through decreasing BCL-xL and MCL-1 expression [30]. The gene discussed is BCL2L1; the disease is osteosarcoma.